205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-10.32%
Revenue decline while MCHP shows 10.54% growth. Joel Greenblatt would examine competitive position erosion.
-8.84%
Cost reduction while MCHP shows 10.84% growth. Joel Greenblatt would examine competitive advantage.
-13.87%
Gross profit decline while MCHP shows 10.35% growth. Joel Greenblatt would examine competitive position.
-3.96%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-3.29%
R&D reduction while MCHP shows 6.35% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.47%
Operating expenses reduction while MCHP shows 9.40% growth. Joel Greenblatt would examine advantage.
-6.72%
Total costs reduction while MCHP shows 10.14% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
85.45%
D&A growth above 1.5x MCHP's 9.84%. Michael Burry would check for excessive investment.
-72.60%
EBITDA decline while MCHP shows 11.21% growth. Joel Greenblatt would examine position.
-69.45%
EBITDA margin decline while MCHP shows 0.60% growth. Joel Greenblatt would examine position.
-51.78%
Operating income decline while MCHP shows 11.73% growth. Joel Greenblatt would examine position.
-46.23%
Operating margin decline while MCHP shows 1.07% growth. Joel Greenblatt would examine position.
-106.82%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-61.67%
Pre-tax income decline while MCHP shows 10.56% growth. Joel Greenblatt would examine position.
-57.26%
Pre-tax margin decline while MCHP shows 0.01% growth. Joel Greenblatt would examine position.
-79.22%
Tax expense reduction while MCHP shows 8.70% growth. Joel Greenblatt would examine advantage.
-53.37%
Net income decline while MCHP shows 11.30% growth. Joel Greenblatt would examine position.
-48.01%
Net margin decline while MCHP shows 0.69% growth. Joel Greenblatt would examine position.
-49.18%
EPS decline while MCHP shows 11.33% growth. Joel Greenblatt would examine position.
-49.18%
Diluted EPS decline while MCHP shows 11.33% growth. Joel Greenblatt would examine position.
0.03%
Share count reduction exceeding 1.5x MCHP's 0.17%. David Dodd would verify capital allocation.
0.23%
Diluted share reduction below 50% of MCHP's 0.17%. Michael Burry would check for concerns.